Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT04250350

Public ClinicalTrials.gov record NCT04250350. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an open-label, single arm study of 52 weeks duration. The study will assess the safety and efficacy of lebrikizumab in adolescent participants (≥12 to \<18 years weighing ≥40 kilograms) with moderate-to-severe atopic dermatitis (AD) who are candidates for systemic therapy.

Study identification

NCT ID
NCT04250350
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
206 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
12 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 11, 2020 (Actual)
Primary completion
Apr 20, 2022 (Actual)
Completion
Jun 22, 2022 (Actual)
Last update posted
Feb 24, 2023

2020 – 2022

United States locations

U.S. sites
48
U.S. states
21
U.S. cities
41
Facility City State ZIP Site status
Pinnacle Research Group Anniston Alabama 36207 —
Arkansas Research Trials, LLC North Little Rock Arkansas 72117 —
Hope Clinical Research Canoga Park California 91303 —
First OC Dermatology Fountain Valley California 92708 —
MD Studies Fountain Valley California 92708 —
Integrative Skin Science and Research Sacramento California 95825 —
University of California, San Diego/Rady Children's Hospital, San Diego - Pediatric & Adolescent Dermatology San Diego California 92123 —
Southern California Dermatology, Inc. Santa Ana California 92701 —
IMMUNOe International Research Centers Centennial Colorado 80112 —
C&R Research Services USA Coral Gables Florida 33134 —
Florida Academic Centers Research and Education, LLC Coral Gables Florida 33134 —
Pediatric Skin Research, LLC Coral Gables Florida 33146 —
Encore Medical Research Hollywood Florida 33021 —
Solutions Through Advanced Research, Inc. Jacksonville Florida 32256 —
Well Pharma Medical Research Corp. Miami Florida 33143 —
Sanchez Clinical Research Inc Miami Florida 33157 —
Miami Dermatology and Laser Research Miami Florida 33173 —
Park Avenue Dermatology Orange Park Florida 32073 —
ForCare Clinical Research Tampa Florida 33613-1244 —
Georgia Pollens Clinical Research Centers, Inc Albany Georgia 31707 —
Advanced Medical Research Sandy Springs Georgia 30328 —
Georgia Skin & Cancer Clinic Savannah Georgia 31419 —
Northwestern University Chicago Illinois 60611 —
Sneeze, Wheeze, & Itch Associates LLC Normal Illinois 61761 —
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46250 —
Kansas Medical Clinic Topeka Kansas 66614 —
Skin Sciences, PLLC Louisville Kentucky 40217 —
Tulane Univ School of Med New Orleans Louisiana 70112 —
Dermatology and Skin Cancer Specialists Rockville Maryland 20850 —
Great Lakes Research Group, Inc. Bay City Michigan 48706 —
St Joseph Dermatology and Vein Clinic Saint Joseph Michigan 49085 —
Central Dermatology PC St Louis Missouri 63117 —
ALLCUTIS Research Portsmouth New Hampshire 03801 —
Forest Hills Dermatology Group Kew Gardens New York 11415 —
Advanced Asthma and Allergy Watertown New York 13601 —
Ohio Pediatric Research Association Dayton Ohio 45414 —
Central States Research Tulsa Oklahoma 74136 —
Vital Prospects Clinical Research Institute, P.C. Tulsa Oklahoma 74136 —
Paddington Testing Company Inc Philadelphia Pennsylvania 19103 —
Arlington Research Center, Inc Arlington Texas 76011 —
Encore Imaging & Medical Research Houston Texas 77065 —
Cutis Wellness Dermatology Laredo Texas 78041 —
Progressive Clinical Research San Antonio Texas 78213 —
Texas Dermatology and Laser Specialists San Antonio Texas 78218 —
Acclaim Dermatology, PLLC Sugar Land Texas 77497 —
Center for Clinical Studies Webster Texas 77598 —
PI-Coor Clinical Research, LLC Burke Virginia 22015 —
Virginia Clinical Research, Inc. Norfolk Virginia 23502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04250350, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 24, 2023 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04250350 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →